Monash University Handbook 2011 Undergraduate - Unit
PAC4462 - Integrated therapeutics: Neurology and oncology
6 points, SCA Band 0 (NATIONAL PRIORITY), 0.125 EFTSL
Refer to the specific
census and withdrawal dates for the semester(s) in which this unit is offered.
Synopsis
This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.
The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.
Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.
Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc.
It will also deal with principles of palliative care and management of patients at the end of life.
Students will perform a number of tasks which will help with the development of critical thinking skills and oral and written communication skills.
Objectives
- This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.
- The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.
- Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.
- Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc. It will also deal with principles of palliative care and management of patients at the end of life.
- Students will perform a number of tasks which will help with the development of critical thinking skills and oral and written communication skills.
Assessment
Mid Semester test 5%; 2 practicals at 5% each; mid semester test 10%; final exam 75%
Chief examiner(s)
Phillip Bergen
Contact hours
72 hours of formal study per semester (36 hours of lectures, 2 x 3 hour practicals, 2 whole class tutorials, self-directed learning).
Additional information on this unit is available from the faculty at:
http://muso.monash.edu.au/webct/entryPage.dowebct